TXNRD1, the cytosolic selenoprotein thioredoxin reductase 1 (TrxR1), served as a central regulator of the thioredoxin system and may be inhibited pharmacologically to achieve selective killing of cancer cells (36, 37). The gene discussed is TXN; the disease is cancer.